Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,666
Recruiting: 939
Ph III recruiting: 109
Growth YoY: +14.9%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 151–158 of 158 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04294264	TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer	active not recruiting	Phase 2	50	Rutgers, The State University of New JerseyOTHER	1	Nov 18, 2024	clinicaltrials
NCT04898504	HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.(EXCALIBUR1+2)	active not recruiting	Phase 2	45	Oslo University HospitalOTHER